J L Chiasson

Summary

Country: Canada

Publications

  1. ncbi Glucose turnover and gluconeogenesis during pregnancy in women with and without insulin-dependent diabetes mellitus
    J L Chiasson
    Research Group on Diabetes and Metabolic Regulation, Institut de Recherches Cliniques de Montreal, Que
    Clin Invest Med 20:140-51. 1997
  2. ncbi The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Depe
    J L Chiasson
    Centre Hospitalier de l Universite de Montreal, Department of Medicine, University of Montreal, Quebec, Canada
    Diabetes Care 21:1720-5. 1998
  3. ncbi Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data
    J L Chiasson
    Research Centre, Centre Hospitalier de l Universite de Montreal Hotel Dieu, Department of Medicine, University of Montreal, 3850 St Urbain Street, Rm 8 202, Montreal, Quebec H2W 1T7, Canada
    Diabetologia 47:969-75; discussion 976-7. 2004
  4. ncbi Effect of acarbose on insulin sensitivity in elderly patients with diabetes
    G S Meneilly
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Diabetes Care 23:1162-7. 2000
  5. ncbi Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro)
    R Rabasa-Lhoret
    , Department of Medicine, University of Montreal, , Canada
    Diabetes Care 24:625-30. 2001
  6. ncbi Estimating insulin secretion in youth using simple indices derived from the oral glucose tolerance test
    M Henderson
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 1020, Pine Avenue West, Room 27, Montreal, Quebec, H3A 1A2, Canada
    Diabetes Metab 38:309-15. 2012
  7. ncbi Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis
    I Hammana
    Diabetes Research Group, Research Center, Centre hospitalier de l Université de Montréal CHUM Hôtel Dieu, Montreal, Quebec, Canada
    Diabetes Metab 33:213-9. 2007
  8. ncbi The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes
    J L Chiasson
    Research Group on Diabetes and Metabolic Regulation, Research Center, Centre Hospitalier de l Universite de Montreal, 3850 St Urbain, 8 202, Montreal, Quebec, Canada H2W 1T8
    Diabetes Care 24:989-94. 2001
  9. ncbi Use of an alpha-glucosidase inhibitor to maintain glucose homoeostasis during postprandial exercise in intensively treated Type 1 diabetic subjects
    R Rabasa-Lhoret
    Research Group on Diabetes and Metabolic Regulation, Research Centre, , Montreal, Quebec, Canada
    Diabet Med 18:739-44. 2001
  10. ncbi Measuring insulin sensitivity in youth: How do the different indices compare with the gold-standard method?
    M Henderson
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada
    Diabetes Metab 37:72-8. 2011

Detail Information

Publications17

  1. ncbi Glucose turnover and gluconeogenesis during pregnancy in women with and without insulin-dependent diabetes mellitus
    J L Chiasson
    Research Group on Diabetes and Metabolic Regulation, Institut de Recherches Cliniques de Montreal, Que
    Clin Invest Med 20:140-51. 1997
    ..To characterize the effect of pregnancy on glucose turnover and gluconeogenesis in healthy women and in women with well-controlled insulin-dependent diabetes mellitus (IDDM)...
  2. ncbi The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Depe
    J L Chiasson
    Centre Hospitalier de l Universite de Montreal, Department of Medicine, University of Montreal, Quebec, Canada
    Diabetes Care 21:1720-5. 1998
    ....
  3. ncbi Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data
    J L Chiasson
    Research Centre, Centre Hospitalier de l Universite de Montreal Hotel Dieu, Department of Medicine, University of Montreal, 3850 St Urbain Street, Rm 8 202, Montreal, Quebec H2W 1T7, Canada
    Diabetologia 47:969-75; discussion 976-7. 2004
    ..The investigators stand strongly behind these results demonstrating that acarbose treatment is associated with a delay in the development of diabetes, hypertension and cardiovascular complications in a high-risk population with IGT...
  4. ncbi Effect of acarbose on insulin sensitivity in elderly patients with diabetes
    G S Meneilly
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Diabetes Care 23:1162-7. 2000
    ..To study the effect of acarbose, an alpha-glucosidase inhibitor, on insulin release and insulin sensitivity in elderly patients with type 2 diabetes...
  5. ncbi Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro)
    R Rabasa-Lhoret
    , Department of Medicine, University of Montreal, , Canada
    Diabetes Care 24:625-30. 2001
    ....
  6. ncbi Estimating insulin secretion in youth using simple indices derived from the oral glucose tolerance test
    M Henderson
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 1020, Pine Avenue West, Room 27, Montreal, Quebec, H3A 1A2, Canada
    Diabetes Metab 38:309-15. 2012
    ..For this reason, this study examined the correlation between OGTT-derived and fasting-based indices of insulin secretion against the acute insulin response to glucose (AIRg) in children...
  7. ncbi Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis
    I Hammana
    Diabetes Research Group, Research Center, Centre hospitalier de l Université de Montréal CHUM Hôtel Dieu, Montreal, Quebec, Canada
    Diabetes Metab 33:213-9. 2007
    ..Since these conditions are common in cystic fibrosis (CF), we examined whether adiponectin values are altered in these patients...
  8. ncbi The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes
    J L Chiasson
    Research Group on Diabetes and Metabolic Regulation, Research Center, Centre Hospitalier de l Universite de Montreal, 3850 St Urbain, 8 202, Montreal, Quebec, Canada H2W 1T8
    Diabetes Care 24:989-94. 2001
    ..To investigate the efficacy and safety of miglitol in combination with metformin in improving glycemic control in outpatients in whom type 2 diabetes is insufficiently controlled by diet alone...
  9. ncbi Use of an alpha-glucosidase inhibitor to maintain glucose homoeostasis during postprandial exercise in intensively treated Type 1 diabetic subjects
    R Rabasa-Lhoret
    Research Group on Diabetes and Metabolic Regulation, Research Centre, , Montreal, Quebec, Canada
    Diabet Med 18:739-44. 2001
    ....
  10. ncbi Measuring insulin sensitivity in youth: How do the different indices compare with the gold-standard method?
    M Henderson
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada
    Diabetes Metab 37:72-8. 2011
    ....
  11. ncbi No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes
    A Godbout
    Endocrinology Division, Department of Medicine, Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    Diabetes Metab 34:568-73. 2008
    ..This study aimed to examine the relationship between mean plasma glucose and HbA(1c) or fructosamine in stable patients with CFRD...
  12. ncbi Postprandial hyperglycaemia: to treat or not to treat?
    M C Brindisi
    Research Group on Diabetes and Metabolic Regulation, Research Center, Centre hospitalier de l Université de Montréal CHUM and Department of Medicine, Universite de Montreal, Quebec, Canada
    Diabetes Metab 32:105-11. 2006
    ..There is growing evidence that treating postprandial hyperglycaemia should probably be part of the strategies for the prevention and management of cardiovascular diseases in pre-diabetes as well as in diabetes...
  13. ncbi The prevention of type 2 diabetes: what is the evidence?
    J L Chiasson
    Research Group on Diabetes and Metabolic, Regulation Research Center, Centre Hospitalier de l Universite de Montreal, Montreal, Canada
    Minerva Endocrinol 30:179-91. 2005
    ..Prevention of the disease is our only chance to alleviate the ever growing burden of diabetes mellitus in the world...
  14. ncbi Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
    G R Dagenais
    Laval University Heart and Lung Institute, 2725 Chemin Ste Foy, Quebec, Quebec City, Canada
    Diabetes Care 31:1007-14. 2008
    ..We determined the effects of ramipril and rosiglitazone on combined and individual CVD and renal outcomes in people with IGT and/or IFG in the Diabetes REduction Assessment With ramipril and rosiglitazone Medication (DREAM) trial...
  15. ncbi Effect of hypercorticism on regulation of skeletal muscle glycogen metabolism by epinephrine
    L Coderre
    Clinical Research Institutes of Montreal, University of Montreal, Quebec, Canada
    Am J Physiol 262:E434-9. 1992
    ..It is suggested that this abnormality could be due to the inhibition of phosphorylase a by increased muscle adenosine levels...
  16. ncbi Chronic exposure to beta-hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes
    A Tardif
    Department of Medicine, Research Center, , University of Montreal, Montreal H2W 1T8, Canada
    Am J Physiol Endocrinol Metab 281:E1205-12. 2001
    ..These results indicate that prolonged exposure to ketone bodies altered insulin action in cardiomyocytes and suggest that this substrate could play a role in the development of insulin resistance in the heart...
  17. ncbi The use of information technology for the management of intensive insulin therapy in type 1 diabetes mellitus
    Y Boukhors
    Research Group on Diabetes and Metabolic Regulation, Research Centre, , , , 3850 St. Urbain Street, Montreal, Quebec, Canada H2W 1T7
    Diabetes Metab 29:619-27. 2003
    ..CONCLUSIONS: The study demonstrated that the use of computer software by the patient to adjust insulin doses for intensive insulin therapy is feasible and is not associated with increased adverse events...